Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Res ; 57(12): 2434-9, 1997 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-9192822

RESUMO

Tyrphostins are low molecular weight compounds that specifically inhibit protein tyrosine kinases. We studied the effects of tyrphostins on OCI-Ly8, a cell line derived from a patient with immunoblastic lymphoma that carries the t(14;18) translocation and overexpresses the B-cell lymphoma/leukemia-2 gene (bcl-2). To test the possibility that tyrphostins induce apoptosis in these cells, overcoming the protection rendered by bcl-2, we screened 16 tyrphostins representing different families at a concentration of 0.5-50 microM. We found that AG17 was the most potent in this regard. Cell cycle analysis demonstrated that AG17 induces arrest at the G1 phase followed by apoptosis with general reduction of the intracellular level of tyrosine-phosphorylated proteins. To further elucidate the mechanism of action of AG17, we investigated its effect on some of the key proteins that regulate the cell cycle. Bcl-2 and cdk2 protein levels were not altered with AG17, whereas cdk2 kinase activity, as well as p21 and p16 protein levels, were reduced markedly. These results suggest that the target of AG17 is inactivation of cdk2. Because lymphoma cells with the t(14;18) translocation and bcl-2 overexpression are resistant to chemotherapy, novel drugs selectively able to induce apoptosis in these cells could offer a new approach to the treatment of lymphoma patients.


Assuntos
Apoptose , Quinases relacionadas a CDC2 e CDC28 , Quinases Ciclina-Dependentes/metabolismo , Linfoma/metabolismo , Nitrilas/farmacologia , Fenóis/farmacologia , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Tirfostinas , Trifosfato de Adenosina/metabolismo , Proteínas de Transporte/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Quinase 2 Dependente de Ciclina , Inibidor p16 de Quinase Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/metabolismo , Inibidores Enzimáticos/farmacologia , Fase G1 , Humanos , Inibidores da Síntese de Ácido Nucleico , Fosforilação/efeitos dos fármacos , Células Tumorais Cultivadas
2.
J Mol Biol ; 238(4): 501-13, 1994 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-8176741

RESUMO

The regulatory region of SV40 is composed of multiple elements, including the origin of replication (ori), the encapsidation signal (ses) and the enhancer. Here, the structure of the chromatin and nucleoprotein complexes in a region encompassing ses and part of the enhancer was investigated in detail by in situ probing with DNase I. We have used a model experimental system based on plasmids which carry parts of the SV40 regulatory region. The results demonstrate that a specific nucleoprotein structure at the region is formed early after transfection. The overall structure is maintained throughout the viral life cycle. The observed DNase digestion pattern is consistent with the presence of a mixed population of viral minichromosomes with various, but not random, nucleosomal arrangements in that region. Specific modulations, which are associated with the various stages of the viral life cycle, are superimposed on the general structure. The most dramatic changes occur at nucleotides 34 and 113, located at both ends of ses and flanking the GC-box region. Some of the changes depend on the presence of viral gene product(s), probably a late (capsid) protein. The results further suggest that the condensed minichromosome within the viral particle assumes a highly specific configuration in this region. The nucleoprotein structure is sensitive to modifications of the primary nucleotide sequence and to flanking DNA elements. There is good correlation between distortions in the nucleoprotein structure and the inability of mutant plasmids to be packaged, substantiating the requirement for proper chromatin condensation in viral packaging.


Assuntos
Cromatina/química , DNA Viral/biossíntese , Nucleoproteínas/química , Sequências Reguladoras de Ácido Nucleico/genética , Vírus 40 dos Símios/crescimento & desenvolvimento , Proteínas Virais/química , Replicação Viral/genética , Animais , Sequência de Bases , Linhagem Celular , Cromatina/metabolismo , DNA Viral/metabolismo , Desoxirribonuclease I , Hibridização In Situ/métodos , Dados de Sequência Molecular , Mutação/genética , Conformação de Ácido Nucleico , Plasmídeos , Vírus 40 dos Símios/genética , Vírus 40 dos Símios/fisiologia , Transfecção
3.
Hum Gene Ther ; 8(7): 843-9, 1997 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-9143910

RESUMO

SV40 is an attractive potential vector with high-efficiency gene transfer into a wide variety of human tissues, including the bone marrow, a critical target organ for the cure of many diseases. In the present study, the three SV40 capsid proteins, VP1, VP2, and VP3, were produced in Spodoptera frugiperda (Sf9) insect cells. Their co-production led to spontaneous assembly of SV40-like particles. Nuclear extracts containing the three proteins were allowed to interact with purified SV40 DNA, or with plasmid DNA produced and purified from Escherichia coli. The experiments demonstrated a physical association between the DNA and capsid proteins, protection from DNase I digestion, and the formation of infectious particles. The results indicate that intact, supercoiled DNA is being packaged and transmitted into the target cells. The transmitted DNA is biologically functional in gene expression and replication. The process, which utilizes naked DNA, is not dependent on the SV40 packaging signal ses. The procedure allows packaging of plasmids significantly larger than SV40 and permits the inclusion of potent regulatory signals, such as beta-globin locus control region (LCR) elements. These studies are the first step in the development of purified, in vitro-constructed pseudovirions for experimental and medical use.


Assuntos
Capsídeo/genética , Vetores Genéticos , Vírus 40 dos Símios/fisiologia , Animais , Proteínas do Capsídeo , Extratos Celulares , Linhagem Celular , Núcleo Celular , Chlorocebus aethiops , DNA Viral , Genes Virais , Terapia Genética , Humanos , Plasmídeos , Proteínas Recombinantes de Fusão/genética , Vírus 40 dos Símios/genética , Spodoptera/citologia , Vírion , Montagem de Vírus
5.
Virology ; 237(2): 414-21, 1997 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-9356352

RESUMO

Soluble SV40 capsid proteins were obtained by expression of the three late genes, VP1, VP2, and VP3, in Sf9 cells using baculovirus expression vectors. Coproduction of the capsid proteins VP1, VP2, and VP3 was achieved by infecting Sf9 cells with the three recombinant baculovirus species at equal multiplicities. All three proteins were found to be localized in the nuclear fraction. Electron microscopy of nuclear extracts of the infected cells showed an abundance of SV40-like capsid structures and heterogeneous aggregates of variable size, mostly 20-45 nm. Under the same staining conditions wild-type SV40 virions are 45 nm. The capsid-like particles sedimented in glycerol gradients similarly to authentic wild-type SV40 virions. Pentamers of the major capsid protein VP1 were also seen. Protein analysis on sucrose gradients demonstrated that the capsid-like particles can be disrupted by treatment with the reducing agent dithiothreitol and the calcium chelator EGTA. The capsid-like particles were found to be significantly less stable than SV40 virions and were partially stabilized by calcium ions. Understanding the complex interactions between the capsid proteins is important for the development of an efficient in vitro packaging system for SV40 virions and pseudovirions.


Assuntos
Capsídeo/química , Capsídeo/metabolismo , Vírus 40 dos Símios/metabolismo , Animais , Western Blotting , Capsídeo/genética , Capsídeo/ultraestrutura , Linhagem Celular , Insetos , Microscopia Eletrônica , Ligação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/ultraestrutura
6.
J Virol ; 74(22): 10381-9, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11044082

RESUMO

Mini-adenoviruses (mAd) deleted of all viral coding regions represent an emerging approach for transgene expression. We have exploited the unique features of the adeno-associated virus (AAV) terminal repeats within the context of an adenovirus-adeno-associated hybrid virus (Ad/AAV) as a strategy for rapid and efficient generation of mAd. Excision and generation of mAd from the parental Ad/AAV hybrid vector was achieved in 293 cells through recombination but without selection for mAd production. Analysis of mAd isolated from 293 cells indicated that mAd DNA exists as monomer and dimer forms within the recombinant viral capsid. Formation of recombinant mAd was significantly increased using an AAV Rep78- or Rep68-expressing cell line through Rep-mediated excision utilizing the AAV terminal repeat sequences present in the Ad/AAV hybrid virus genome. The mAd viruses were infectious and able to transfer functional gene to A549 and HeLa cells. This approach is rapid and efficient, thereby providing a simplified methodology for generating mAd with functional transducing capabilities.


Assuntos
Adenoviridae/genética , Proteínas de Ligação a DNA/metabolismo , Dependovirus/metabolismo , Vetores Genéticos , Recombinação Genética , Proteínas Virais/metabolismo , Adenoviridae/metabolismo , Animais , Linhagem Celular , Proteínas de Ligação a DNA/genética , Dependovirus/genética , Células HeLa , Humanos , Proteínas Virais/genética , Replicação Viral
7.
Gene Ther ; 8(3): 232-8, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11313795

RESUMO

The potential of gene therapy to treat premalignant disease or recurrent cancer has not been investigated. The goal of the present investigation was to explore the efficacy of pro-drug-mediated, suicide gene therapy as a strategy to treat incipient neoplasia in stratified squamous epithelium. To test this strategy, a tissue model of premalignancy was generated by mixing normal human keratinocytes (NHK) that express the bacterial cytosine deaminase gene (CD) with premalignant keratinocytes which have been genetically marked with the bacterial gene for beta-galactosidase (II-4-beta-gal) in skin-like organotypic cultures. Preliminary studies in monolayer cultures demonstrated that CD-transduced NHK (NHK/CD) efficiently expressed the transgene and deaminated the pro-drug 5-fluorocytosine (5FC) to the toxic product 5-fluorouracil (5FU). The capacity of NHK/CD to kill II-4-beta-gal cells through bystander effect was assayed in both submerged culture and in the organotypic model of premalignancy. In submerged cultures, it was found that CD-mediated killing of II-4-beta-gal cells did not require cell-cell contact and that the LD(50) of 5FC for efficient bystander killing of II-4-beta-gal was 0.5 mM. When this concentration of pro-drug was used in organotypic cultures, a significant number of dysplastic II-4-beta-gal cells were eliminated from the tissue. Bystander killing of II-4-beta-gal cells was related to the number of NHK/CD present. These findings demonstrated that potentially malignant keratinocytes could be eliminated from a dysplastic tissue through activation of pro-drug and killing of adjacent cells through the bystander effect. By establishing an in vitro model to eliminate premalignant cells using suicide gene therapy, these studies provide a new approach for the treatment of incipient cancer as it develops, thereby preventing invasive disease.


Assuntos
Carcinoma in Situ/terapia , Terapia Genética/métodos , Neoplasias Bucais/terapia , Lesões Pré-Cancerosas/terapia , Antimetabólitos/farmacologia , Técnicas de Cultura de Células , Morte Celular/efeitos dos fármacos , Citosina Desaminase , Relação Dose-Resposta a Droga , Flucitosina/farmacologia , Expressão Gênica , Humanos , Recém-Nascido , Queratinócitos/efeitos dos fármacos , Queratinócitos/enzimologia , Masculino , Nucleosídeo Desaminases/genética , Pró-Fármacos/farmacologia
8.
J Virol ; 66(9): 5320-8, 1992 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1323699

RESUMO

Encapsidation of simian virus 40 is a complex biological process involving DNA-protein and protein-protein interactions in the formation of a unique three-dimensional structure around the viral minichromosome. A pseudoviral system developed in our laboratory, in which the viral early and late gene products are supplied in trans (by helpers), was used to analyze the encapsidation process independent of viral gene expression. With this experimental system we have discovered a requirement for a specific DNA signal for encapsidation, ses (for simian virus 40 encapsidation signal).ses is present within a 200-bp DNA fragment, which includes, in addition to the viral origin of replication (ori), six GGGCGG repeats (GC boxes) and 26 bp of the enhancer element. Deletion of the GC boxes and the enhancer sequences almost abolished encapsidation, while DNA replication was only moderately decreased. The ability to encapsidate was not regained by reinserting a DNA fragment carrying ses in the sesdeleted plasmid 2 kbp away from the ori, suggesting that for encapsidation the two DNA elements have to be close to each other. These findings afford novel strategies for the investigation of viral encapsidation.


Assuntos
Capsídeo/biossíntese , Sequências Reguladoras de Ácido Nucleico/genética , Vírus 40 dos Símios/crescimento & desenvolvimento , Vírus 40 dos Símios/genética , Replicação Viral/genética , Animais , Sequência de Bases , Linhagem Celular , Cloranfenicol O-Acetiltransferase/biossíntese , Chlorocebus aethiops , Análise Mutacional de DNA , Vetores Genéticos/genética , Vírus Auxiliares/genética , Rim/citologia , Rim/microbiologia , Dados de Sequência Molecular , Plasmídeos/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA